1. Search Result

Search Result

Results for "WNK4 Inhibitors" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-100626

    Ser/Thr Protease Cancer
    WNK463 is an orally bioavailable pan-With-No-Lysine (K) (WNK)-kinase inhibitor with IC50s of 5 nM, 1 nM, 6 nM, and 9 nM for WNK1, WNK2, WNK3, and WNK4, respectively.
  • HY-112143

    Others Cardiovascular Disease
    STOCK2S-26016 is a WNK signalling inhibitors. STOCK2S-26016 inhibits WNK4 and WNK1 with IC50s of 16 μM and 34.4 μM, respectively. STOCK2S-26016 has potential for antihypertensive research.